cardiovascular disease

are we helping our patients make the best therapy decisions?

One-day meeting for physicians, GPs, specialist nurses and pharmacists

Wednesday 23 May 2018

Royal Institution
21 Albemarle Street, Piccadilly, London
W1S 4BS


This meeting starts in

programme

This meeting is now FULLY SUBSCRIBED
Use this email link to join the waitlist

Supported by an unrestricted educational grant from Bayer UK

Programme

9.00

Registration with coffee

9.30

Welcome and Introduction
Chair

Is there such a thing as “best” therapy?

9.35

What is involved in shared decision making
Professor Angela Coulter, University of Oxford

10.00

I’m a patient: what matters to me is…
Trudie Lobban, CEO, AF Association

10.25

I’m a clinician, what the guidelines say is…
Professor Martin R Cowie, Imperial College London

10.45

Practical tips on decision making
Alun Roebuck, Consultant Nurse in Cardiology

11.05

Panel discussion

11.30

Coffee break

How can we assess risk best?

12.00

Heart age – a better concept than 10 year risk?
Dr Susan B Connolly, Consultant Cardiologist, Western Health and Social Care Trust, Enniskillen

12.20

CHADSVASC and HASBLED: any better than the UK weather forecast?
Dr Ami Banerjee, University College London

12.40

Enough high science – what can we do in daily practice?
Dr Matt Fay, General Practitioner, Bradford

1.00

Panel discussion

1.30

Lunch

Looking to the future: have we reached the limits or can we reduce risk further?

2.30

Diabetes: how can we minimise vascular risk?
Professor Miles Fisher University of Glasgow

2.50

The forgotten many: peripheral arterial disease
Professor Nick Cheshire, Imperial College London

3.10

Vascular Checks in Primary Care: do they work?
Dr Matt Fay, General Practitioner, Bradford

3.30

Update on new drugs
Professor Martin R Cowie, Imperial College London

3.50

Panel discussion

4.20

Summary and conclusions
Professor Martin R Cowie, London

4.30

Programme ends

Venue

Meetings in 2017

Heart Failure 2017: making a diffence


The meeting and this Newsletter were funded by Novartis. Editorial control remained with Logos Healthcare Communications.

Novatis logo

Heart Failure: innovation and implementation

The meeting and these webcasts were funded by Bayer Healthcare. Editorial control remained with Logos Healthcare Communications.
Bayer logo

Past meetings

Get in touch

C/O the office of:
Professor Martin R Cowie
National Heart and Lung Institute
Dovehouse Street
London, SW3 6LY

Email: info@logoscommunications.co.uk